Announcements
HAPTIX program pioneers new prosthetic technology
Researchers at the West Virginia University Center for Neuroscience are developing a new approach to prosthetics that could offer amputees an artificial hand that feels and responds like a real hand.
$1.5M WVU Eye Institute grant to address glaucoma in the Caribbean
Anthony Realini, M.D., M.P.H., a glaucoma specialist in the West Virginia University Eye Institute, has received a $1.5 million grant from the National Eye Institute to conduct a five-year study aimed at finding better ways to address the problem of glaucoma on the Caribbean islands of Dominica and St. Lucia.
One month left to join Program ACTIVE diabetes study
Depression affects one in four people with type 2 diabetes. Program ACTIVE is looking for participants to help test two of the most effective ways to treat it: exercise and talk therapy.
WVU: Individual reports available to those affected by C8 contamination
West Virginia University, as a steward of the data collected in the 2005-2006 Brookmar C8 Health Project Study, has made individual reports of the study’s findings available to each of the 69,030 participants who took part in the court-ordered community health study to document the leaked chemical’s health effects on affected residents.
WVU Public Health professor to provide real-time data from local fracking site over next five years
Michael McCawley, Ph.D., interim chair of the West Virginia University School of Public Health Department of Occupational and Environmental Health Sciences, plans to provide research data in real time from a dedicated scientific observation well being drilled in Morgantown.
WVU research shows promise for reducing risk of breast cancer spreading to the brain
Generally speaking, women diagnosed with breast cancer are surviving longer and having better outcomes. While one in eight women will develop breast cancer during their lifetime, the vast majority will beat the disease. However, 10 to 15 percent of those diagnosed may see their cancer spread to another part of their body. Research led by Paul Lockman, Ph.D., B.S.N., the inaugural Douglas Glover Chair of Pharmaceutical Sciences at the West Virginia University School of Pharmacy and associate director for translational research at the Mary Babb Randolph Cancer Center, seeks to better understand why and how breast cancer can spread to the brain with the goal of developing a way to reduce the risk of this phenomenon.
WVU Coach Huggins competes in Infiniti Coaches Charity Challenge to benefit cancer research
West Virginia University Men’s Basketball Coach Bob Huggins is one of 48 top college basketball coaches in the nation participating in the Infiniti Coaches’ Charity Challenge. He is looking to Mountaineer fans for their support to help him win $100,000 for the Norma Mae Huggins Cancer Research Endowment at the WVU Mary Babb Randolph Cancer Center.
WVCTSI announces new funding for community-based research
The West Virginia Clinical and Translational Science Institute (WVCTSI) released its request for applications (RFA) for community-based clinical and translational pilot projects targeting health disparities in West Virginia and Appalachia.
First Exchange Bank makes gift to WVU Cancer Center for breast cancer research
First Exchange Bank and its six branch offices in West Virginia have donated $2,500 to the West Virginia University Mary Babb Randolph Cancer Center for its Breast Cancer Research Program.
WVU School of Medicine research helps unlock mysteries of schizophrenia
Researchers at West Virginia University, in collaboration with an international consortium of geneticists and clinicians from Switzerland, France, Greece, and Germany, are working to understand the genetic basis of schizophrenia by sequencing those blueprints of the human genome for individuals diagnosed with the disorder, along with those of his or her healthy parents (trios). They have identified 18 different genes that possibly influence the incidence of schizophrenia, including Regulator of G protein Signaling type 12 (RGS12) that was originally cloned by WVU’s David Siderovski, Ph.D., and his colleagues in 1997.